122 related articles for article (PubMed ID: 27267924)
1. Use of MicroRNA biomarkers to distinguish enchondroma from low-grade chondrosarcoma.
Zhang L; Yang M; Mayer T; Johnstone B; Les C; Frisch N; Parsons T; Mi QS; Gibson G
Connect Tissue Res; 2017 Mar; 58(2):155-161. PubMed ID: 27267924
[TBL] [Abstract][Full Text] [Related]
2. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma.
Shooshtarizadeh T; Nazeri A; Zare-Mirzaie A; Movahedinia S
Pathol Res Pract; 2016 Apr; 212(4):335-9. PubMed ID: 26948096
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel biomarker candidates for immunohistochemical diagnosis to distinguish low-grade chondrosarcoma from enchondroma.
Lai X; Chen S
Proteomics; 2015 Jul; 15(13):2358-68. PubMed ID: 25755173
[TBL] [Abstract][Full Text] [Related]
4. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
Joseph NM; McGill KC; Horvai AE
Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
6. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of estrogen receptors in chondrosarcomas and enchondromas.
Grifone TJ; Haupt HM; Podolski V; Brooks JJ
Int J Surg Pathol; 2008 Jan; 16(1):31-7. PubMed ID: 18203781
[TBL] [Abstract][Full Text] [Related]
9. Intracellular cholesterol biosynthesis in enchondroma and chondrosarcoma.
Zhang H; Wei Q; Tsushima H; Puviindran V; Tang YJ; Pathmanapan S; Poon R; Ramu E; Al-Jazrawe M; Wunder J; Alman BA
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039139
[TBL] [Abstract][Full Text] [Related]
10. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
[TBL] [Abstract][Full Text] [Related]
11. Clonal chromosome abnormalities in enchondromas and chondrosarcomas.
Gunawan B; Weber M; Bergmann F; Wildberger J; Niethard FU; Füzesi L
Cancer Genet Cytogenet; 2000 Jul; 120(2):127-30. PubMed ID: 10942802
[TBL] [Abstract][Full Text] [Related]
12. The expression of miR-181a-5p and miR-371b-5p in chondrosarcoma.
Mutlu S; Mutlu H; Kirkbes S; Eroglu S; Kabukcuoglu YS; Kabukcuoglu F; Duymus TM; ISık M; Ulasli M
Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2384-8. PubMed ID: 26214773
[TBL] [Abstract][Full Text] [Related]
13. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
[TBL] [Abstract][Full Text] [Related]
14. What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas?
Douis H; Parry M; Vaiyapuri S; Davies AM
Eur Radiol; 2018 Jan; 28(1):398-409. PubMed ID: 28695356
[TBL] [Abstract][Full Text] [Related]
15. PAS inclusions, immunoreactive tenascin and proliferative activity in low-grade chondrosarcomas.
Ranty ML; Michot C; Le Pessot F; Hellot MF; Biga N; Dujardin FH; Simonet J; Billerey C; Metayer J
Pathol Res Pract; 2003; 199(1):29-34. PubMed ID: 12650515
[TBL] [Abstract][Full Text] [Related]
16. Radiographic differentiation of enchondroma from low-grade chondrosarcoma in the fibula.
Kendell SD; Collins MS; Adkins MC; Sundaram M; Unni KK
Skeletal Radiol; 2004 Aug; 33(8):458-66. PubMed ID: 15221215
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of human chondrosarcomas for matrix production and cancer markers.
Söderström M; Böhling T; Ekfors T; Nelimarkka L; Aro HT; Vuorio E
Int J Cancer; 2002 Jul; 100(2):144-51. PubMed ID: 12115562
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
19. DNA flow cytometric analysis of chest-wall chondroma and chondrosarcoma.
Shih CS; Wang LS; Yang SS; Fahn HJ; Wu LH; Chen WY; Huang MH
Scand J Thorac Cardiovasc Surg; 1996; 30(3-4):157-61. PubMed ID: 8976036
[TBL] [Abstract][Full Text] [Related]
20. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features.
Murphey MD; Flemming DJ; Boyea SR; Bojescul JA; Sweet DE; Temple HT
Radiographics; 1998; 18(5):1213-37; quiz 1244-5. PubMed ID: 9747616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
